Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) ...
The Nintendo Switch may be one of the most innovative consoles ever, all thanks to its namesake ability to switch between TV and handheld play. Nintendo’s joy-cons were initially a game changer, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback